NICE 20 Aug 2026
Ex-situ machine perfusion devices to preserve deceased donor livers for transplantation
HTG780
20 Aug 2026
Read →
These trials are currently recruiting participants in the UK. Always speak to your GP or specialist before contacting a trial team.
Researchers want to learn more about tulisokibart (also known as MK-7240) in an extension study. Tulisokibart is a medicine designed to treat…
This phase III, double-blind, multi-center treat-through study will evaluate the efficacy and safety of Afimkibart (also known as RO7790121) in children with…
The purpose of this study is to assess how well JNJ-78934804 works (efficacy) and how safe it is (safety) as compared to…
The purpose of this protocol is to evaluate the efficacy (how well it works), safety and tolerability of oral icotrokinra as therapy…
The purpose of this protocol is to evaluate the efficacy of MK-8690 in participants with moderately to severely active ulcerative colitis. The…
The purpose of this study is to assess how well guselkumab works when compared to risankizumab in participants with moderately to severely…
Living with Gut & Digestion? Your experience can help others. Share what you've learned.
Thousands of UK patients are managing Gut & Digestion. Connect, share experiences, and support each other.
The latest pipeline drugs, clinical breakthroughs, and regulatory approvals from the FDA, EMA and NICE for Gut & Digestion patients.
HTG780
📋 Information sourced from clinical trial registries, FDA, EMA and published research
View all research →Detailed condition pages for Gut & Digestion are coming soon.
No podcasts available yet for Gut & Digestion
Sign up for updates below to be notified when we release a free patient podcast for this area.